☰
Johnson & Johnson, a multinational medical device & pharmaceuticals company, has recently announced its plan to commence the human trial of a potential COVID-19 vaccine by the 2nd half of July 2020. The drug ma...
Read More >>New Wave Holdings Corp., a Canadian company that focuses on entertainment and esports facilities, has recently announced that it would support the Delos Psyche Research Group in its research on determining the impact o...
Read More >>Ever since COVID-19 has ravaged the globe, claiming more than 3 lakh lives, various research organizations and scientists the world over, have been striving to introduce a vaccine or a medication or a potential method ...
Read More >>In the face of the ongoing pandemic spread worldwide, that has disrupted businesses and turned normal lives upside down, companies have been striving to bring about innovative solutions that can ensure people to remain adequately and correctly inf...
Read More >>Health authorities in South Korea have lately announced the ongoing medical examination of two children cited as suspected cases of a life-threatening syndrome associated with coronavirus. The two children are apparent...
Read More >>The analysis examines impact of migraine in areas of Spain, France, and the United Kingdom. Migraine has been one of the prominent neurological condit...
Read More >>Scientists at Peking University in China have successfully conducted tests for a new drug which they claim could help in containing the coronavirus pandemic. Since its outbreak in China, the disease continues to be a m...
Read More >>Moderna, Inc., an American biotechnology company, recently announced that its coronavirus vaccine candidate has produced protective antibodies among a group of healthy volunteers. E...
Read More >>Gilead Sciences, an American biopharmaceutical company, has recently inked non-exclusive licensing pacts with 5 India- and Pakistan-based generic drug-makers. These licensing agreements have been made to increase the s...
Read More >>South Korea has delayed the process of reopening schools by a week due to the fears of possible 2nd wave of COVID-19 infections. The latest coronavirus cases stem from a new cluster traced to 5 clubs and bars in Itaewon. The number of infe...
Read More >>The world has joined forces to develop a vaccine for COVID-19 and companies across the globe are scrambling for the first breakthrough. Since the coronavirus spreads easily and is already weakening the healthcare syste...
Read More >>Gilead Sciences, an American biopharmaceutical company, has recently engaged in talks with some leading chemical & pharmaceutical companies in countries including India. The discussion has been held on remdesivir, ...
Read More >>Singapore’s health statutory board, the Health Sciences Authority (HSA) has recently deleted over 1,700 listings of products from local websites that were falsely making COVID-19-related claims. These products in...
Read More >>UK scientists have developed a new drug for treating coronavirus patients that will be put to trial in the University Hospital at Southampton. UK-based biotech firm, Synairgen has developed this drug which uses the pro...
Read More >>Daniel Andrews, the Premier of Victoria, has reportedly stated that 100,000 COVID-19 tests will be conducted in 2 weeks ahead of easing of stage 3 restrictions. Mr. Andrews has adde...
Read More >>As the debate on hydroxychloroquine’s effectiveness over COVID-19 intensifies, a significant number of physicians across the globe still presume that patients should consume the drug to treat the symptoms of COVI...
Read More >>Ramsay Health Care, a leading provider of healthcare services in Australia, Malaysia, Indonesia and the U.K, has reportedly welcomed a plan proposed by Australia to resume elective surgeries, considering it as a decent...
Read More >>Novartis has received approval from the U.S. Food and Drug Administration for clinical trials to study the efficacy of hydroxychloroquine, which is essentially a drug for malaria, for the treatment of hospitalized pati...
Read More >>The university’s vaccine programme has hired around 510 people to take part in the first trial. As the deadly coronavirus have paved its way to almost every c...
Read More >>As the COVID-19 pandemic has significantly increased the demand for ventilators, leading manufacturers worldwide have responded quickly by surging production. However, ventilator manufacturers are still waiting to get ...
Read More >>Amidst growing concerns over the coronavirus, numerous medical institutes and pharmaceutical companies are diligently working on developing an effective vaccine to tackle this deadly virus. France’s Sanofi S.A. a...
Read More >>In a bid to curb the spread of coronavirus, several medical institutes and researchers are conducting striding initiatives like community-wide testing and drug development. Recently, the University of Minnesota and May...
Read More >>AIVITA Biomedical, Inc., a biotech firm developing innovative cell therapies, has recently announced updates to the survival data after the year-end analysis of the ongoing AV-GBM-1 Phase 2 clinical trial in newly diag...
Read More >>Walgreens, a leading drug store chain in the United States recently announced plans to open 15 drive-thru facilities for coronavirus COVID-19 testing in seven states. With mounting ...
Read More >>Gilead Sciences, Inc., an American biotechnology company, has recently announced its plan to donate 1.5 million doses of the investigational drug, remdesivir. These 1.5 million doses will be used for over 140,000 treat...
Read More >>As COVID-19 cases continue to soar in America, medical professionals on the front lines are facing a shortage of masks and other protective equipment. To cope up with increasing demand, The Home Depot Inc., one of the ...
Read More >>Analytics 4 Life, one the leading digital health company committed to improving existing diagnostic pathways, has reportedly presented data on its heart failure research at the ACC’s (American College of Cardiolo...
Read More >>The U.S.-based biotechnology company, 1CellBio Inc. has recently revealed early access program for its latest droplet-based targeted cell sequencing and selection abilities. Reportedly, this latest approach aligns with...
Read More >>Leuven-based biotech firm miDiagnostics has recently concluded a €14 million investment round. The funding round was led by leading life science and technology investors, including Dr. Ir. Urbain Vandeurzen and Dr...
Read More >>As the coronavirus pandemic reaches community level, prominent companies have come forward to aid medical researchers in accelerating their drug development process. ATUM, an American biotechnology firm, recently made ...
Read More >>InMed Pharmaceuticals Inc., a leading biopharmaceutical company which develops medications targeting diseases with unmet needs, has reportedly announced the filing of CTA (Clinical Trial Application) in the Netherlands...
Read More >>Vapotherm, Inc., a global medical technology firm developing and manufacturing proprietary Hi-VNI Technology products, has reportedly announced an update on its business in response to the COVID-19 pandemic. ...
Read More >>The pharmaceutical firm will prioritize resources towards COVID-19 pandemic Phase 2 trial in MS patients will commence once the hospitals hav...
Read More >>Saniona, a renowned biopharmaceutical firm focusing on rare disorders of the central nervous system, has reportedly announced that the last patient has successfully completed the last visit in the company’s six-m...
Read More >>CERo Therapeutics, Inc., the privately-owned biopharma firm, recently announced that it will be collaborating for research with Lyell Immunopharma, Inc. for the development of next-gen cell-based immunotherapy solution...
Read More >>The series A funding round was led by Optum Ventures and .406 ventures The company aims at expanding the delivery of advanced virtual cardiovascula...
Read More >>The trial monitors infigratinib in the post-surgery treatment of invasive urothelial carcinoma Volunteers with a high risk of cancer ...
Read More >>The SARS CoV-2 standard has human genomic DNA and synthetic COVID-19 RNA transcripts. SARS CoV-2 standard assists laboratories to kee...
Read More >>UnitedHealth Group Inc., an American healthcare company offering a full spectrum of health benefit programs for employers, individuals, and medicaid beneficiaries, has reportedly launched a new benefit program to suppo...
Read More >>CytoDyn Inc., announced that it has submitted a Phase 2 protocol with the U.S. Food and Drug Administration (FDA) for a basket trial under its cancer IND. The company can instantly start enrollment in this trial to off...
Read More >>Alkahest will initiate Phase 2 trial for AKST4290, an inhibitor to treat Parkinson’s disease The firm has been partly funded by The Michael J...
Read More >>Moleculin Biotech, Inc., a preclinical pharmaceutical company and developer of anti-cancer drug candidates, has recently announced the completion of its US Phase 1 trial. The open label, single arm clinical trial met i...
Read More >>The threat of coronavirus needs to be addressed as early as possible, particularly since there are no particular treatments or vaccines currently available for patients suffering from coronavirus globally. As the count...
Read More >>The tablet would offer superior performance as well as premium design for AAC users. EyeTech Digital Systems, a leading innovator in Health AI, has recently launche...
Read More >>Under the exclusive genetics supply agreement, the parties would possibly acquire and import high-THC genetics for Terrace’s medical cannabis operations in the state of Portugal. The company is all s...
Read More >>Advanced Sterilization Products (ASP) has secured 510(k) clearance from the U.S. FDA. The regulatory body has approved for a 15-min time to result on the STERRAD VELOCITY® Biological Indicator (BI)/P...
Read More >>Omnicell, Inc., a U.S. based company that offers adherence tools for healthcare systems and pharmacies along with medication management solutions, has recently revealed that it would be presenting its medication management portfolio’s latest...
Read More >>Quest Diagnostics announced the acquisition of genetic testing firm, Blueprint Genetics to extend access to actionable insights in genetic and rare diseases. The acquisition is aimed at enhancing patient care and boost...
Read More >>The U.S. FDA (Food and Drug Administration), a federal agency of the U.S. Department of Health and Human Services, has reportedly approved teprotumumab-trbw (Tepezza) to treat adults suffering from thyroid eye disease....
Read More >>DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmente...
Read More >>Tmunity Therapeutics Inc., a clinical-stage biotherapeutics firm focused on advanced T-cell immunotherapy, has reportedly dosed the first patient in its Phase 1 CART-TnMUC1-01 clinical trial with TnMUC1 (Tn/STn glycofo...
Read More >>The merger will bring two therapeutic immune-oncology platforms together Focus shall be placed over Phase 1 and Phase 2 trials of CAR-CIK and CMN-0...
Read More >>Adverum Biotechnologies, a California based biotech company, has reportedly announced that it has examined its recent business & development progress. The company has also unveiled its outlook for 2020. ...
Read More >>Adverum Biotechnologies, Inc., a U.S. based biotechnology company that develops innovative therapies for ocular and rare diseases, has announced its first patient data from the OPTIC phase 1 clinical study of ADVM-022,...
Read More >>Immunic, a renowned biopharmaceutical company focused on treating autoimmune and chronic inflammatory diseases, reportedly announced that its subsidiary, Immunic AG, has implemented its exclusive global license option ...
Read More >>DTM waveform will help improve the outcome for patients with chronic pain The transaction will remain neutral to earnings per share f...
Read More >>The report will contain data of CAR-T product candidate called BNT211, an autologous CAR-T cell therapy BioNTech SE, a biotechnology firm based in Germany, recently...
Read More >>Innate Pharma SA, a commercial-stage oncology-focused biotech firm, has successfully attain Marketing Authorization Application (MMA) approval for Lumoxiti from the European Medicines Agency (EMA). For the record, Lumo...
Read More >>BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging artificial intelligence approaches to advance the next wave of medicines in immuno-oncology and neuroscience, has reportedly announced the ...
Read More >>Starpharma, a world leader in dendrimer product development, reportedly announced that AstraZeneca, a renowned British-Swedish biopharmaceutical company, has initiated a phase 1 clinical study of AZD0466. The first pat...
Read More >>Clinical-stage biopharmaceutical company, Spring Bank Pharmaceuticals, Inc. has reportedly stopped patient dosing and enrollment in its Phase 2b CATALYST studies that aim at evaluating the use of inarigivir soproxil 40...
Read More >>The clinical trial was aimed at the treatment of uncomplicated urinary tract infections. The enrollment is expected to garner topline results in q...
Read More >>Lineage Cell Therapeutics, a California based clinical stage biotechnology company, that develops novel cellular therapies for medical needs that are not fulfilled, has reportedly announced its plans to enter into lice...
Read More >>HIV AIDS cases have been prevailing and increasingly growing across the world. Currently, about 37.9 million people are suffering from HIV globally. Several global pharmaceutical firms are increasingly working and inve...
Read More >>Seattle Genetics, Inc., a biotechnology company based in U.S., and Astellas Pharma Inc. have recently revealed that the U.S. Food and Drug Administration (FDA) has given PADCEV™ an accelerated approval for treati...
Read More >>The deal is anticipated to close in the third quarter of 2020, subject to relevant regulatory approvals and other customary closing terms. Cigna has reportedly anno...
Read More >>TransThera will initiate a Phase 1 clinical trial for TT-00920 in early 2020 TT-00920 is believed to be a new transformative treatmen...
Read More >>The optical sensors are designed to integrate into Union Medical’s Neo Thermos Neo Thermos is utilized to treat tumors without ...
Read More >>Myriad Genetics, Inc., a company focused on precision medicine and molecular diagnostics, has reportedly presented the result of a new validation study of its polygenic risk score (PRS) for breast cancer at the 2019 Sa...
Read More >>The genomics company announced the launch of Targeted Locus Amplification (TLA) technology for complete cancer gene mutation sequencing. ...
Read More >>ProQR Therapeutics NV, a renowned Dutch biopharmaceutical company dedicated on finding treatments for rare genetic diseases, has reportedly announced the dosage of first patient in Phase 1/2 Aurora study of QR-1123....
Read More >>Merck, a renowned American pharmaceutical company also known as MSD outside Canada and the United States, reportedly announced the acquisition of ArQule, a US-based biopharmaceutical firm focused on finding novel thera...
Read More >>The updated results were presented in poster session at the ASH annual meeting The study shows strong data for DPX-Survivac in combin...
Read More >>Kura Oncology, Inc., a biopharmaceutical firm based in the U.S., has recently revealed regulatory and clinical updates of its foremost drug candidate, Tipifarnib, designed to target AITL (angioimmunoblastic T-cell lymp...
Read More >>Amneal Pharmaceuticals, Inc. has made some consistent ripples in the generics and specialty pharmaceutical industry. Recently, the company made headlines when it revealed attaining final approval from the U.S. FDA on its ANDA (Abbreviated New Drug...
Read More >>Prescient Therapeutics, a renowned small molecule drug development firm aimed at developing new cancer therapies, reportedly announced that it is extending its Phase 1b trial in patients with AML (acute myeloid leukemi...
Read More >>Equillium Inc., a clinical-stage biotechnology company, has reportedly announced that it will be presenting positive data related to the role CD6-ALCAM pathway as a relevant target for patients who are suffering from a...
Read More >>As an innovative technology, artificial intelligence can effectively be used to tackle the challenges faced by today’s healthcare industry. Hospitals are keenly looking for ways to serve patients, both in terms o...
Read More >>It has been reported that various industry giants across the medical fraternity have been involved in the mergers and collaborations to develop and commercialize the treatments for distinguished disorders and diseases....
Read More >>Novartis has reportedly planned the purchase with a target of adding inclisiran, a potential cholesterol lowering drug of The Medicines Company to its existing cardiovascular portfolio ...
Read More >>Lower rates of cardiovascular hospitalizations and mortality were witnessed. Echocardiographic paramete...
Read More >>FDA’s new warning letter is asking Dollar Tree to ensure the company does not import adulterated medicines Manufacturers mentio...
Read More >>Cellectis, a French biopharmaceutical company that aims to innovate immunotherapies based on gene-edited allogeneic CAR T-cells, recently revealed a report issued in Nature Communications that explains a proo...
Read More >>Arranta has established a Center of Excellence for microbiome development The acquisition will help quicken the delivery of LBPs for ...
Read More >>Reports confirm that CytoDyn Inc., a late-stage biotechnology company has announced that it has recently received approval from the Institutional Review Board for leronlimab, to be directed to triple-n...
Read More >>FDA declines approval of Lipocine’s oral drug Tlando for third time Reportedly, the oral drug Tlando was first declined approva...
Read More >>GW Pharmaceuticals plc has reportedly announced that two of its medicines, Sativex (nabiximols) and EPIDYOLEX (cannabidiol) oral solution, have been advised by National Institute for Health and Care Excellence (NICE) of the U.K. to get routine com...
Read More >>The test senses antibodies to HIV 1 and HIV 2, demonstrated specificity of 100% and sensitivity of 99.4%, when comparing amateur HIV self-test users to skilled professionals. ...
Read More >>The pharmaceutical sector is often held accountable for treating the most crucial health conditions. The sector markets, innovates and produces those therapies which could become beneficial to patients on a larger scal...
Read More >>Pandion Therapeutics, Inc. and Astellas Pharma Inc. have reportedly inked a license and collaboration deal for researching, developing and commercializing pancreas-targeting immunomodulators. ...
Read More >>© 2024 ReportsGO.com. All Rights Reserved.